1. Home
  2. BEAM vs LZB Comparison

BEAM vs LZB Comparison

Compare BEAM & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • LZB
  • Stock Information
  • Founded
  • BEAM 2017
  • LZB 1927
  • Country
  • BEAM United States
  • LZB United States
  • Employees
  • BEAM N/A
  • LZB N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • LZB Home Furnishings
  • Sector
  • BEAM Health Care
  • LZB Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • LZB Nasdaq
  • Market Cap
  • BEAM 1.9B
  • LZB 1.8B
  • IPO Year
  • BEAM 2020
  • LZB N/A
  • Fundamental
  • Price
  • BEAM $24.41
  • LZB $45.43
  • Analyst Decision
  • BEAM Buy
  • LZB Hold
  • Analyst Count
  • BEAM 10
  • LZB 1
  • Target Price
  • BEAM $47.67
  • LZB N/A
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • LZB 344.0K
  • Earning Date
  • BEAM 02-25-2025
  • LZB 02-18-2025
  • Dividend Yield
  • BEAM N/A
  • LZB 1.94%
  • EPS Growth
  • BEAM N/A
  • LZB 4.44
  • EPS
  • BEAM N/A
  • LZB 2.90
  • Revenue
  • BEAM $349,643,000.00
  • LZB $2,070,500,000.00
  • Revenue This Year
  • BEAM N/A
  • LZB $3.32
  • Revenue Next Year
  • BEAM $14.08
  • LZB $3.97
  • P/E Ratio
  • BEAM N/A
  • LZB $15.45
  • Revenue Growth
  • BEAM 328.73
  • LZB N/A
  • 52 Week Low
  • BEAM $20.84
  • LZB $32.00
  • 52 Week High
  • BEAM $49.50
  • LZB $46.47
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 42.12
  • LZB 62.24
  • Support Level
  • BEAM $22.50
  • LZB $44.33
  • Resistance Level
  • BEAM $28.39
  • LZB $44.52
  • Average True Range (ATR)
  • BEAM 1.56
  • LZB 1.02
  • MACD
  • BEAM -0.33
  • LZB 0.18
  • Stochastic Oscillator
  • BEAM 27.67
  • LZB 93.37

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; and Retail, which sells upholstered and case goods furniture to the end consumer. The majority of the company's revenue is derived from its Wholesale segment.

Share on Social Networks: